Susquehanna International Group, LLP Glycomimetics Inc Put Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 07, 2024	BUY	$2.55 - $3.49 $252,194 - $345,161	98,900 Added 575.0%	116,100 $348,000
Q4 2023 Feb 14, 2024	SELL	$1.13 - $2.54 $3,954 - $8,890	-3,500 Reduced 16.91%	17,200 $40,000
Q3 2023 Nov 14, 2023	SELL	$1.29 - $1.73 $25,929 - $34,773	-20,100 Reduced 49.26%	20,700 $31,000
Q2 2023 Aug 11, 2023	BUY	$1.21 - $2.08 $22,143 - $38,064	18,300 Added 81.33%	40,800 $70,000
Q1 2023 May 16, 2023	BUY	$1.25 - $4.05 $28,125 - $91,125	22,500 New	22,500 $28,000

17.8M

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $16.3M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.